Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet‐derived growth factor BB

16 Jan 2019

Abstract excerpt

ETS transcription factors play important roles in tumor cell invasion, differentiation and angiogenesis. In this study, we initially demonstrated that ETS translocation variant 5 (ETV5) is abnormally upregulated in colorectal cancer (CRC), is positively correlated with CRC tumor size, lymphatic metastasis and tumor node metastasis (TNM) stage and indicates shorter survival and disease-free survival in CRC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis and VEGF in Cancer
Share to Genetic factors in colorectal cancer
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30650178
DOI: 10.1002/ijc.32071

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet‐derived growth factor BBPMID 30650178Read ↗

Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancerSemantic proximity Read ↗

Targeting tumor cell-derived CCL2 as a strategy to overcome bevacizumab resistance in ETV5+ colorectal cancerSemantic proximity Read ↗

The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progressionSemantic proximity Read ↗

Identification of ETV5 as a prognostic marker related to epigenetic modification in pan-cancer and facilitates tumor progression in hepatocellular carcinomaSemantic proximity Read ↗

E26 transformation-specific transcription variant 5 in development and cancer: modification, regulation and functionSemantic proximity Read ↗

ETV5 expression positively correlates with promoter methylation and predicts response for 5-FU-based adjuvant therapy response in proximal colon cancerSemantic proximity Read ↗

Biological and prognostic value of ETV5 in high-grade serous ovarian cancerSemantic proximity Read ↗

ETV5 overexpression promotes progression of esophageal squamous carcinoma by upregulating SKA1 and TRPV2Semantic proximity Read ↗

ITGB5 is a prognostic factor in colorectal cancer and promotes cancer progression and metastasis through the Wnt signaling pathwaySemantic proximity Read ↗

The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer CellsSemantic proximity Read ↗

E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanismsSemantic proximity Read ↗

ETV4 facilitates proliferation, migration, and invasion of liver cancer by mediating TGF-β signal transduction through activation of B3GNT3Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.